Market Research Reports - Ken Research Global Drug Delivery Technology Market Research

Increasing lifestyle diseases in Spain demand for uncontaminated drug administration using
innovative drug delivery devices: Ken Research
The increase in occurrences of chronic diseases in Spain has triggered a growth in biologics
market, technological advancements and introduction of new products. The improvement in
efficacy of drug delivery, drug safety along with controlling the rate of drug delivery, time, and
place of drug release in the body are the major elements affecting the drug delivery
technologies. Almost all the companies are manufacturing smart and fast technologies which
offer effective treatments for diseases. Majority of manufacturing companies are investing
huge funds in the research and development of drug delivery systems that cater to the needs of
patients for effective delivery of drugs.
The leading players in global drug delivery technology market are Johnson & Johnson, Inc.
(U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer,
Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company
(U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.). The
applications of drug delivery devices are at hospitals, ambulatory surgical centers, home care
settings, diagnostic centers, other facilities such as medical data centers, research and clinical
laboratories. Drug Delivery devices are used to administer medical drugs via Oral, Injectable,
Topical, Ocular, Nasal, Pulmonary, Transmucosal, and Implantable.
The introduction of central venous catheters (CVCs) in Spain has created healthcare reforms
with a positive impact and safety. It was observed that CVC’s are the best practices of using and
managing invasive devices. CVC’s prevents and control healthcare-associated infections in
hospitals, outpatient settings, and home healthcare settings along with associated
complications. These key factors led to an increased adoption rate of CVCs in healthcare
centres Spain. The increasing awareness about the antimicrobial technology has led to
increasing adoption of antimicrobial CVCs. The central venous catheters in Spain are segmented
into antimicrobial, non-antimicrobial, and non-tunneled catheter devices. The non-tunneled
CVCs are also known as subclavian, percutaneous, and short-term catheters which are used as
an alternative to peripherally inserted central catheters (PICC). Healthcares facilitating dialysis
procedures for urological and renal disorders witness an increased influx of patients and a large
requirement of catheterization. The applications of CVC’s are at multi-specialty hospitals,
private hospitals, and hospital groups.
The leading players in the CVC’s in Spain are Teleflex Inc, C. R. Bard Inc, Edwards Lifesciences
Corp and B. Braun Melsungen AG. The other vendors in central venous catheters market are
Vygon, Cook, Amecath, AngioDynamics, BACTIGUARD, BD, Biosensors International, Boston
Scientific, CONMED, Guangdong Baihe Medical Technology, Intra special catheters, isomed,